Table 5.
Country | Participating sites and principal investigatorsa |
---|---|
Belgium | Herman Tournaye, UZ Brussel; Petra De Sutter, UZ Gent; Wim Decleer, AZ Jan Palfijn AV, Gent. |
Brazil | Alvaro Petracco, Fertilitat – Centro de Medicina Reproductiva, Porto Alegre; Edson Borges, Fertility – Centro de Fertilizacao Assistida, São Paulo; Caio Parente Barbosa, Instituto Ideia Fértil de Saúde Reproductiva, São Paulo. |
Canada | Jon Havelock, Pacific Centre for Reproductive Medicine, Burnaby, British Columbia; Paul Claman, Ottawa Fertility Centre, Ottawa, Ontario; Albert Yuzpe, Olive Fertility Centre, Vancouver, British Columbia. |
Czech Republic | Hana Visnova, IVF CUBE SE, Prague; Pavel Ventruba, Centre of Assisted Reproduction, Brno; Petr Uher, Institute of Reproductive Medicine and Genetics, Karlovy Vary; Milan Mrazek, GYNEM, Prague. |
Denmark | Anders Nyboe Andersen, The Fertility Clinic, Copenhagen University Hospital, Copenhagen; Ulla Breth Knudsen, The Fertility Clinic, Aarhus University Hospital, Skejby. |
France | Didier Dewailly, Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre; Anne Guivarc'h Leveque, Clinique Mutualiste La Sagesse. |
Italy | Antonio La Marca, University of Modena and Reggio Emilia, Modena; Enrico Papaleo, Centro Natalità San Raffaele, Milan. |
Poland | Waldemar Kuczynski, Kriobank, Bialystok; Katarzyna Kozioł, nOvum Fertility Clinic, Warsaw. |
Russia | Margarita Anshina, Centre of Reproduction & Genetics – LLC, Moscow; Irina Zazerskaya, Federal State Budgetary Institution “Federal Center of Heart, Blood & Endocrinology named after V.I. Almazov” of Ministry of Health of the Russian Federation, Saint Petersburg; Alexander Gzgzyan, Institute of Russian Academy of Medical Science Scientific Research Institute of Gynaecology and Obstetrics named after D.O. Ott of North-West Department of RAMS, Saint Petersburg; Elena Bulychova, State Budgetary Health Institution of Moscow Region “Moscow Regional Scientific Research Institute of Obstetrics & Gynaecology.” |
Spain | Victoria Verdú, Genefiv, Madrid; Pedro Barri, Hospital Universitario Quirón Dexeus, Barcelona; Juan Antonio García-Velasco, IVI Madrid, Madrid; Manuel Fernández-Sánchez, IVI Sevilla, Seville; Fernando Sánchez Martin, Ginemed, Seville; Ernesto Bosch, IVI Valencia, Valencia; José Serna, IVI Zaragoza, Zaragoza; Gemma Castillon; IVI Barcelona, Barcelona; Rafael Bernabeu, Instituto Bernabeu, Alicante; Marcos Ferrando, IVI Bilbao, Bilbao. |
UK | Stuart Lavery, Boston Place Clinic, London, England; Marco Gaudoin, Glasgow Centre for Reproductive Medicine, Glasgow, Scotland. |
aIn total, 37 sites from 11 countries participated in ESTHER-1 and 32 of the 37 sites participated in ESTHER-2
ESTHER Evidence-based Stimulation Trial with Human rFSH in Europe and Rest of World